Ilab Mechnikov

  • HOME
    • ABOUT US
    • HISTORY OF THE COMPANY
  • NEWS AND EVENTS
  • PRODUCTS
    • VACCINE ANTIFLU INACTIVATED FRACTIONATED
    • FLU-M (FRACTIONAL INACTIVATED FLUE VACCINE)
    • MANUFACTURING BY CONTRACT
  • PHARMACOVIGILANCE
  • CONTACTS
  • CORONAVIRUS (COVID-19)
  • EnglishEnglish
    • EspañolEspañol
  • Home
  • NEWS AND EVENTS
  • NEWS AND EVENTS
  • Final GMP audit was carried out at the MECHNIKOV plant

Final GMP audit was carried out at the MECHNIKOV plant

Tuesday, 15 January 2019 / Published in NEWS AND EVENTS

Final GMP audit was carried out at the MECHNIKOV plant

From January 14 to January 18, 2019, experts from the Cuban regulatory authority CECMED have been conducting the final GMP audit.

It should be remembered that the final audit was preceded by intense work carried out by specialists from the MECHNIKOV Institute in December.

Thus, from December 3 to 7, 2018, the MFT (Media Fill Test [esp. Media Fill Test]) was bottled. It is a test of the simulation of the filling of the vials that represents a critical stage in the control and validation of aseptic processes to confirm the sterility of the production facilities. During the three-series MFT, the sterility and microbiological purity of the filling process has been demonstrated.

After filling, samples were taken from the primary container to carry out their control. The results obtained from December 17 to 21, 2018 determined the absence of endotoxins and the microbiological purity (sterility) of the samples from the three MFT series.

Similarly, from December 16 to 18, 2018, a validation series of the vaccine for the prevention of influenza was completed (<em> in bulk </em>, the vaccine was previously delivered by the IICVSSP). The results of the quality control of the filling of the validation series that we obtained in early January 2019 determined the absence of endotoxins and the microbiological purity (sterility).

What you can read next

Russia collaborates in the delivery of medicine against the coronavirus from Cuba.
Russian biotechnology offers to fight coronavirus in Latin America
The Nicaraguan Mechnikov vaccine plant has all the capabilities to produce the retroviral used to counter the new coronavirus.
283 days agoRusia colabora en la entrega de medicamento contra el coronavirus desde Cuba. https://t.co/ySMo1GCPFp
over a year agohttps://t.co/ijMnLwozjD
Follow @ilabmechnikov

Mechnikov © 2020. All rights reserved.

TOP